SCA Pharma recalls neostigmine methylsulfate 5 mg/5 mL injection with potential lack of sterility. This prescription drug may pose infection risks if used.
Lack of Assurance of Sterility
SCA Pharma is recalling neostigmine methylsulfate injections due to a lack of sterility assurance. This could lead to infections if the medication is used without proper sterility.
The injection may not be sterile, which could cause infections if used. This is a medication for specific medical conditions, not for general use.
Prescription patients using this specific neostigmine injection. Those with medical conditions requiring this medication are most at risk.
Check for the product name 'neostigmine methylsulfate 5 mg/5 mL Injection', NDC 70004-0750-09, and lot number 1223048138 (expiring 1/31/2024).
Verify the product name, NDC number, and expiration date to confirm if it's recalled.
The recall states there is a lack of sterility assurance, which could lead to infections. Do not use this product.
The recall does not specify a remedy, so contact your healthcare provider for guidance.
Look for the product name 'neostigmine methylsulfate 5 mg/5 mL Injection', NDC 70004-0750-09, and lot number 1223048138 (expiring 1/31/2024).
We’ve drafted a message you can send SCA Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0413-2024 — SCA Pharma SCA Pharma Hello, I own a SCA Pharma that is covered by recall D-0413-2024 from SCA Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
